Table 2.

Long-term survival model for hepatocellular carcinoma patients after liver transplantation

Variables	Regression coefficient	Regression coefficient SE	P value	Hazard ratio	95%CI
Milan1
AFP (logevalue)	0.093	0.031	0.003	1.097	1.032-1.167
Intraoperative blood loss	0.038	0.009	< 0.001	1.039	1.021-1.057
Retransplantation	1.429	0.522	0.006	4.173	1.501-11.604
Criteria exceeded	1.504	0.253	< 0.001	4.500	2.741-7.386
University of California San Francisco2
AFP (logevalue)	0.090	0.031	0.003	1.094	1.030-1.161
Intraoperative blood loss	0.038	0.009	< 0.001	1.039	1.022-1.057
Retransplantation	1.373	0.522	0.009	3.947	1.419-10.976
Criteria exceeded	1.555	0.242	< 0.001	4.737	2.950-7.607
Shanghai Fudan3
AFP (logevalue)	0.091	0.031	0.003	1.096	1.031-1.165
Intraoperative blood loss	0.034	0.008	< 0.001	1.035	1.018-1.052
Retransplantation	1.296	0.523	0.013	3.654	1.311-10.182
Criteria exceeded	1.361	0.213	< 0.001	3.899	2.566-5.924
Hangzhou4
TB (logevalue)	0.186	0.094	0.049	1.204	1.001-1.449
Intraoperative blood loss	0.020	0.010	0.046	1.020	1.000-1.040
Retransplantation	1.312	0.520	0.012	3.715	1.340-10.295
Criteria exceeded	1.520	0.190	< 0.001	4.570	3.149-6.633

¹MHCAT (Milan) = 0.093 × LnAFP + 0.038 × IBL + 1.429 × Re (Re = 0 without retransplantation; Re = 1 with retransplantation) + 1.504 × Cri (Cri = 0 within criteria; Cri = 1 exceeding criteria);

²MHCAT (University of California San Francisco) = 0.090 × LnAFP + 0.038*IBL + 1.373 × Re (Re = 0 without retransplantation; Re = 1 with retransplantation) + 1.555 × Cri (Cri = 0 within criteria; Cri = 1 exceeding criteria);

³MHCAT (Fudan) = 0.091 × LnAFP +0.034 × IBL + 1.296 × Re (Re = 0 without retransplantation; Re = 1 with retransplantation) + 1.361 × Cri (Cri = 0 within criteria; Cri = 1 exceeding criteria);

⁴MHCAT (Hangzhou) = 0.186 × LnTB + 0.020 × IBL + 1.312 × Re (Re = 0 without retransplantation; Re = 1 with retransplantation) + 1.520 × Cri (Cri = 0 within criteria; Cri = 1 exceeding criteria). TB: Total bilirubin; AFP: Alfa-fetoprotein.